Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT06824441

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Conditions: Adolescent Behavior, Pediatric Cancer, Oncology

Sex: All
Ages: 7 Years – 21 Years
Healthy volunteers: No
Phase: NA
Enrollment: 85
Sponsor: Stanford University

Location: Stanford University Palo Alto California

Summary

The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.

Eligibility Criteria

Inclusion Criteria: 1. First diagnosis of cancer 2. Receiving cancer therapy: surgery, myelosuppressive chemotherapy and/or radiation 7-21 years of age 3. Completed at least 1 month of cancer chemotherapy treatment and are within 7-28 days of starting a treatment cycle or during ongoing therapy, followed at least every month in clinic 4. If surgery was part of treatment, the patient must be 3-6 weeks post surgery before participating in study 5. Caregiver must be present and 18 years and older 6. Ability to understand and the willingness to personally sign the written IRB-approved informed consent or assent document as appropriate 7. Disease can be newly diagnosed, in relapse or refractory, as long as this is the first diagnosis of cancer 8. Child must be able to read or listen to and understand English Exclusion Criteria: 1\. Child must not have cognitive/memory impairments determined by the child's clinician

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06824441). StuddyBuddy aggregates publicly available trial information.